Join Today! Register Now. Growth Calculator Wizard Norditropin My Diary Tools and Resources Step Up For Haiti Important Safety Information

What Is Norditropin®?

Norditropin® is a man-made form of growth hormone called "recombinant human growth hormone." Although it's made in a lab, it is identical to the growth hormone your body makes. Norditropin® was approved for use in the United States in 1995. This means you can feel confident in making it your own growth hormone therapy.

Norditropin® has been approved by the FDA to help children who:

  • Have growth failure because of low or no growth hormone
  • Are short (in stature) and who have Noonan syndrome
  • Are short (in stature) and have Turner syndrome
  • Are short (in stature) because they were born small (small for gestational age-SGA) and have not caught up by age 2 to 4 years

Norditropin® can also help adults who do not make enough growth hormone.

For more information about any of these conditions please click here.

Treatment That Works
With Your Life

Only Norditropin® is available in the FlexPro® and NordiFlex® pens. These pens were designed to be easy to use and convenient to store:

  • The pens come pre-filled and pre-loaded so you'll never have to stop your day to mix, load, or change a cartridge.
  • After first use, some of our pens don't require refrigeration and can be kept at room temperature (up to 77°F) for up to 3 weeks. No other growth hormone therapy can do that.*
  • NovoFine® needles are some of the smallest needles available.** The NovoFine® Autocover® 30G has a protective outer shield that hides the needle before, during and after the injection. This shield also locks into place after the injection to help reduce needlestick injuries. And it uses the 8-mm NovoFine® 30G needle, which 90% of patients surveyed found practically pain-free.

Besides being easy to learn to use, our pens are "easy" on the environment. The production facilities that make our pens are completely wind powered. In fact, we have already eliminated 12,000 TONS of carbon dioxide emissions.

Click to find out more about the FlexPro® pen.

*All Norditropin® products must be refrigerated prior to first use. Do not freeze. After initial use, FlexPro® 5 mg/1.5 mL and 10 mg/1.5 mL delivery pens can either be stored outside of the refrigerator (at up to 77°F) for use within 3 weeks, or in the refrigerator (between 36°F and 46°F) for use within 4 weeks. The FlexPro® 15 mg/1.5 mL and NordiFlex® 30 mg/3 mL delivery pens must always be refrigerated (between 36°F and 46°F)—both prior to and after the initial injection—for use within 4 weeks.

**Needles are sold separately and may require a prescription in some states.

The Norditropin® Device Pledge

We are so confident that our devices are easy to use and convenient to store that if you are not satisfied with our product after filling 3 paid prescriptions, Novo Nordisk will pay up to $125 off your first co-pay on a competing medicine.

Norditropin® Device Pledge Terms and Conditions
Patients must be new to therapy with Norditropin® but could have previously taken a competing product. Patients receiving copay assistance with NordiSure® are eligible. Patients must provide proof of three paid months of therapy with Norditropin® in compliance with treatment plan, proof of purchase of competing product, and letter stating reason why they are dissatisfied. Offer expires 60 days after the date of the last script filled by the pharmacy. Patients cannot be receiving copay assistance or free product from manufacture of competing project. Novo Nordisk reserves the right to rescind, revoke, or amend this offer with notice at any time. This offer is not valid for individuals who are covered on Medicaid or Medicare and in certain states. Not valid for residents of Massachusetts. Offer good only in the United States.

Check Out Norditropin Products
Check Out Norditropin Parents and Caregivers
Check Out Norditropin Kids
Check Out Norditropin Teens
Check Out Norditropin Adults
Important Safety Information Jump Link

Indications and Usage

Norditropin® (somatropin [rDNA origin] injection) is used to treat: children who have growth failure because of low or no growth hormone; children who are short (in stature) and who have Noonan syndrome or Turner syndrome; children who are short (in stature) because they were born small (small for gestational age-SGA) and have not caught-up in growth by age 2 to 4 years; and adults who do not make enough growth hormone.

Important Safety Information

Do not use Norditropin® if: you have a critical illness caused by certain types of heart or stomach surgery, trauma or breathing (respiratory) problems; you are a child with Prader-Willi syndrome who is severely obese or has breathing problems including sleep apnea; you have cancer or other tumors; your healthcare provider tells you that you have certain types of eye problems caused by diabetes; you are a child with closed bone growth plates (epiphyses) or you are allergic to any of the ingredients in the medicine.

Before you take Norditropin®, tell your healthcare provider if you: have diabetes; had cancer or any tumor; have any other medical condition; are pregnant or plan to become pregnant; are breast-feeding or plan to breast-feed.

Norditropin® can cause serious side effects, including: high risk of death in people who have critical illnesses because of heart or stomach surgery, trauma or serious breathing (respiratory) problems; high risk of death in children with Prader-Willi syndrome who are severely obese or have breathing problems including sleep apnea; return of tumor or cancerous growths; high blood sugar (hyperglycemia); increase in pressure in the skull (intracranial hypertension); swollen hands and feet due to fluid retention; decrease in thyroid hormone levels; hip and knee pain or a limp in children (slipped capital femoral epiphysis); worsening of pre-existing curvature of the spine (scoliosis); middle ear infection, hearing problems or ear problems in patients with Turner syndrome.

Patients with Noonan syndrome and Turner syndrome should be closely monitored by their doctors as they are more likely to have congenital heart disease.

The most common side effects of Norditropin® include: headaches, muscle pain, joint stiffness, high blood sugar (hyperglycemia), sugar in your urine (glucosuria), swollen hands and feet due to fluid retention, and redness and itching in the area you inject. If you have headaches, eye problems, nausea or vomiting (these may be symptoms of raised pressure in the brain), contact your healthcare provider right away.

Norditropin® may affect how other medicines work, and other medicines may affect how Norditropin® works so be sure to tell your healthcare provider about all the medicines you take including prescription and non-prescription medicines, vitamins, and herbal supplements.

Especially tell your healthcare provider if you take: glucocorticoid medication, thyroid hormone, insulin or other medicine for diabetes, medicines that are metabolized by the liver (e.g., corticosteroids, sex steroids, anticonvulsants, cyclosporine), or oral estrogen replacement medicine.

For more information, please click here for complete Norditropin® Prescribing Information.

Norditropin® is a prescription medication.

Novo Nordisk provides patient assistance for those who qualify. Please call 1-866-310-7549 to learn more about Novo Nordisk assistance programs.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088

Norditropin®, FlexPro® and Norditropin NordiFlex® are registered trademarks of Novo Nordisk Health Care AG. NovoFine® and Novo Nordisk® are registered trademarks and Growth Track Wizard™ is a trademark of Novo Nordisk A/S.
Novo Nordisk Inc., 100 College Road West, Princeton, New Jersey 08540 U.S.A.
© 2011 Novo Nordisk    0411-00002479-1    July 2011